Recommendations for the evaluation of risk and prophylaxis of tumour lysis syndrome (TLS) in adults and children with malignant diseases: an expert TLS panel consensus, British Journal of Haematology, vol.149, issue.4, pp.578-586, 2010. ,
The Tumor Lysis Syndrome, New England Journal of Medicine, vol.364, issue.19, pp.1844-1854, 2011. ,
Pathophysiology, clinical consequences, and treatment of tumor lysis syndrome, The American Journal of Medicine, vol.116, issue.8, pp.546-554, 2004. ,
Pathophysiology, clinical consequences, and treatment of tumor lysis syndrome, The American Journal of Medicine, vol.116, issue.8, pp.546-554, 2004. ,
Severe cardiopulmonary complications consistent with systemic inflammatory response syndrome caused by leukemia cell lysis in childhood acute myelomonocytic or monocytic leukemia, Pediatric Blood & Cancer, vol.44, issue.1, pp.63-69, 2004. ,
Acute lysis pneumopathy after chemotherapy for acute myelomonocytic leukemia with abnormal marrow eosinophils, Cancer, vol.69, issue.6, pp.1356-1361, 1992. ,
Super-acute onset of tumor lysis syndrome accompanied by hypercytokinemia during treatment of Hodgkin's lymphoma with ABVD chemotherapy, Clinical Therapeutics, vol.32, issue.3, pp.527-531, 2010. ,
Tumour lysis syndrome after treatment of chronic lymphocytic leukaemia with fludarabine., Postgraduate Medical Journal, vol.70, issue.827, pp.651-652, 1994. ,
Systemic inflammatory response syndrome and multiple organ dysfunction in patients with acute tumor lysis syndrome, Clinics, vol.64, issue.5, pp.479-481, 2009. ,
Tumor lysis syndrome in a case of chronic lymphocytic leukemia induced by high-dose corticosteroids, American Journal of Hematology, vol.54, issue.1, pp.85-86, 1997. ,
Tumour lysis syndrome: an unusual presentation, Anaesthesia, vol.65, issue.10, pp.1031-1033, 2010. ,
Intraoperative tumor lysis-induced fatal hyperkalemia, Journal of Anesthesia, vol.26, issue.6, pp.945-946, 2012. ,
Urgent chemotherapy in hematological patients in the ICU, Current Opinion in Critical Care, vol.21, issue.6, p.1, 2015. ,
Understanding organ dysfunction in hemophagocytic lymphohistiocytosis, Intensive Care Medicine, vol.34, issue.7, pp.1177-1187, 2008. ,
Critical care management of patients with hemophagocytic lymphohistiocytosis, Intensive Care Medicine, vol.36, issue.10, pp.1695-1702, 2010. ,
Intensive care in patients with newly diagnosed malignancies and a need for cancer chemotherapy*, Critical Care Medicine, vol.33, issue.11, pp.2488-2493, 2005. ,
HLH-2004: Diagnostic and therapeutic guidelines for hemophagocytic lymphohistiocytosis, Pediatric Blood & Cancer, vol.48, issue.2, pp.124-131, 2007. ,
Toxicity as a result of immunostimulation by biologics, Expert Opinion on Drug Metabolism & Toxicology, vol.3, issue.2, pp.209-234, 2007. ,
Outcome in severely ill patients with hematological malignancies who received intravenous chemotherapy in the intensive care unit, Intensive Care Medicine, vol.32, issue.1, pp.93-99, 2005. ,
Development and Validation of the HScore, a Score for the Diagnosis of Reactive Hemophagocytic Syndrome, Arthritis & Rheumatology, vol.66, issue.9, pp.2613-2620, 2014. ,
Development and Validation of the HScore, a Score for the Diagnosis of Reactive Hemophagocytic Syndrome, Arthritis & Rheumatology, vol.66, issue.9, pp.2613-2620, 2014. ,
Recent advances in diagnostic and therapeutic guidelines for primary and secondary hemophagocytic lymphohistiocytosis, Blood Cells, Molecules, and Diseases, vol.64, pp.53-57, 2017. ,
Syndrome d?hyperviscosité plasmatique, La Revue de Médecine Interne, vol.36, issue.9, pp.588-595, 2015. ,
Syndrome d?hyperviscosité plasmatique, La Revue de Médecine Interne, vol.36, issue.9, pp.588-595, 2015. ,
Hyperviscosity syndrome, Intensive Care Medicine, vol.44, issue.7, pp.1151-1152, 2018. ,
URL : https://hal.archives-ouvertes.fr/hal-01787150
Evidence-based focused review of management of hyperviscosity syndrome, Blood, vol.119, issue.10, pp.2205-2208, 2012. ,
Respiratory events at the earliest phase of acute myeloid leukemia, Leukemia & Lymphoma, vol.55, issue.11, pp.2556-2563, 2014. ,
Current insights into severe sepsis in cancer patients, Revista Brasileira de Terapia Intensiva, vol.26, issue.4, pp.335-343, 2014. ,
Managing critically Ill hematology patients: Time to think differently, Blood Reviews, vol.29, issue.6, pp.359-367, 2015. ,
Intensive care of the cancer patient: recent achievements and remaining challenges, Annals of Intensive Care, vol.1, issue.1, p.5, 2011. ,
Risk factors to predict outcome in critically ill cancer patients receiving chemotherapy in the intensive care unit, Supportive Care in Cancer, vol.19, issue.4, pp.491-495, 2010. ,
Urgent Chemotherapy for Life-Threatening Complications Related to Solid Neoplasms, Critical Care Medicine, vol.45, issue.7, pp.e640-e648, 2017. ,
Outcomes of Critically Ill Patients With Hematologic Malignancies: Prospective Multicenter Data From France and Belgium?A Groupe de Recherche Respiratoire en Réanimation Onco-Hématologique Study, Journal of Clinical Oncology, vol.31, issue.22, pp.2810-2818, 2013. ,
Outcomes after intensive care unit admission of patients with newly diagnosed lymphoma, Leukemia & Lymphoma, vol.56, issue.5, pp.1240-1245, 2014. ,
Prognostic factors, long-term survival, and outcome of cancer patients receiving chemotherapy in the intensive care unit, Annals of Hematology, vol.93, issue.10, pp.1629-1636, 2014. ,
Systemic inflammation after trauma, Injury, vol.38, issue.12, pp.1336-1345, 2007. ,
The Sequential Organ Failure Assessment score for predicting outcome in patients with severe sepsis and evidence of hypoperfusion at the time of emergency department presentation*, Critical Care Medicine, vol.37, issue.5, pp.1649-1654, 2009. ,
Expression of interleukin-6 and interleukin-6 receptor in Hodgkin's disease, Blood, vol.77, issue.11, pp.2413-2418, 1991. ,
Interleukin-6, but not interleukin-4, is expressed by Reed-Sternberg cells in Hodgkin's disease with or without histologic features of Castleman's disease, Am J Pathol. juill, vol.141, issue.1, pp.129-167, 1992. ,
Functional coexpression of Interleukin (IL)-7 and its receptor (IL-7R) on Hodgkin and Reed-Sternberg cells: Involvement of IL-7 in tumor cell growth and microenvironmental interactions of Hodgkin's lymphoma, Int J Cancer. 1 sept, vol.125, issue.5, pp.1481-1490, 1990. ,
Secretion of interleukin-1 by acute myeloblastic leukemia cells in vitro induces endothelial cells to secrete colony stimulating factors, Blood, vol.70, issue.4, pp.1218-1221, 1987. ,
Circulating mitochondrial DAMPs cause inflammatory responses to injury, Nature, vol.464, issue.7285, pp.104-107, 2010. ,
Septic shock, The Lancet, vol.365, issue.9453, pp.63-78, 2005. ,
URL : https://hal.archives-ouvertes.fr/hal-02159416
Cytokine-induced sickness behaviour: a neuroimmune response to activation of innate immunity, European Journal of Pharmacology, vol.500, issue.1-3, pp.399-411, 2004. ,
URL : https://hal.archives-ouvertes.fr/hal-02676459
Tolerance, Danger, and the Extended Family, Annual Review of Immunology, vol.12, issue.1, pp.991-1045, 1994. ,
Mitochondrial damage-associated molecular patterns and vascular function, European Heart Journal, vol.35, issue.18, pp.1172-1177, 2014. ,
Inside, outside, upside down: damage-associated molecular-pattern molecules (DAMPs) and redox, Trends in Immunology, vol.28, issue.10, pp.429-436, 2007. ,
Hormonal and cytokine effects of uric acid, Current Opinion in Nephrology and Hypertension, vol.15, issue.1, pp.30-33, 2006. ,
Mitochondrial N-formyl peptides induce cardiovascular collapse and sepsis-like syndrome, American Journal of Physiology-Heart and Circulatory Physiology, vol.308, issue.7, pp.H768-H777, 2015. ,
Gestion des chimiothérapies chez les patients hémodialysés, Bulletin du Cancer, vol.99, issue.3, pp.371-380, 2012. ,
Robots, men and sex tourism, Futures, vol.44, issue.4, pp.365-371, 2012. ,
Pharmacokinetic/pharmacodynamic considerations for cancer patients undergoing hemodialysis, Expert Opinion on Drug Metabolism & Toxicology, vol.13, issue.6, pp.617-623, 2017. ,
, Annexe 1: Caractéristiques des systèmes éducatifs
, avec retrait des items « leucémie » et « lymphome » ** Patient décédé à 24h donc explorations concernant le lymphome non réalisées Légende : LB = lymphome B
, Graphique 12.1. Évolution de la valeur des exportations sectorielles et de la part de la valeur ajoutée sur place dans la valeur des exportations brutes, LT = lymphome T ; xN = nombre de fois la valeur normale Annexe 7 : Article publié dans Critical Care Medicine concernant le choc primaire et l'impact de la chimiothérapie sur son évolution